P65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma

Federica Giordano, Valentina Vaira, Diego Cortinovis, Sara Bonomo, Joyce Goedmakers, Federica Brena, Annamaria Cialdella, Leonarda Ianzano, Irene Forno, Maria Grazia Cerrito, Roberto Giovannoni, Gian Luca Ferri, Ennio Tasciotti, Silve Vicent, Francesco Damarco, Silvano Bosari, Marialuisa Lavitrano, Emanuela Grassilli

Research output: Contribution to journalArticle

8 Scopus citations

Fingerprint Dive into the research topics of 'P65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences